» Articles » PMID: 18316821

Recovery of Antimicrobial-resistant Pseudomonas Aeruginosa from Sputa of Cystic Fibrosis Patients by Culture on Selective Media

Overview
Date 2008 Mar 5
PMID 18316821
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To assess the utility of direct plating of whole sputa onto selective media as a means of identifying antimicrobial resistance in strains of Pseudomonas aeruginosa from the sputa of patients with cystic fibrosis (CF).

Methods: A total of 45 sputum samples from CF patients were cultured onto conventional culture media for isolation of P. aeruginosa and were also cultured directly onto Iso-Sensitest agar plates containing each of 10 antimicrobials incorporated at a 'breakpoint' concentration. A representative of each colonial type (morphotype) recovered from both routine media and selective media was tested for its susceptibility to 10 antimicrobials using a standard agar dilution MIC technique.

Results: Of the samples shown to contain resistant strains, the proportion (%) detected using routine media and selective media, respectively, was: 42 and 100 for amikacin, 57 and 100 for gentamicin, 54 and 100 for tobramycin, 88 and 77 for aztreonam, 62 and 90 for ceftazidime, 70 and 97 for meropenem, 61 and 100 for piperacillin/tazobactam, 90 and 86 for temocillin, 66 and 100 for ticarcillin/clavulanic acid, and 80 and 90 for ciprofloxacin resistance. The increased rates of isolation on selective media were statistically significant (P < 0.05) for amikacin, gentamicin, tobramycin, meropenem, piperacillin/tazobactam and ticarcillin/clavulanic acid.

Conclusions: For most antimicrobials, selection of colonies from conventional media for antimicrobial susceptibility testing provided a considerable underestimation of resistance in P. aeruginosa. The use of selective media for the culture of whole sputum was effective for the detection of resistant isolates of P. aeruginosa.

Citing Articles

In search of the best method to detect carriage of carbapenem-resistant Pseudomonas aeruginosa in humans: a systematic review.

Shahab S, van Veen A, Buchler A, Saharman Y, Karuniawati A, Vos M Ann Clin Microbiol Antimicrob. 2024; 23(1):50.

PMID: 38858708 PMC: 11163693. DOI: 10.1186/s12941-024-00707-1.


The Status of Carbapenem Resistance in Cystic Fibrosis: A Systematic Review and Meta-Analysis.

Saadh M, Lohrasbi A, Ghasemian E, Hashemian M, Etemad A, Dargahi Z Yale J Biol Med. 2022; 95(4):495-506.

PMID: 36568834 PMC: 9765336.


A Novel Method to Assess Antimicrobial Susceptibility in Commensal Oropharyngeal -A Pilot Study.

Laumen J, Abdellati S, Van Dijck C, Martiny D, De Baetselier I, Manoharan-Basil S Antibiotics (Basel). 2022; 11(1).

PMID: 35052976 PMC: 8772996. DOI: 10.3390/antibiotics11010100.


Comparison of the effects of versus imipenem on infected burn wound healing.

Soleymanzadeh Moghadam S, Mohammad N, Ghooshchian M, FathiZadeh S, Khodaii Z, Faramarzi M Med J Islam Repub Iran. 2020; 34:94.

PMID: 33315993 PMC: 7722975. DOI: 10.34171/mjiri.34.94.


A Selective, Dual Emission β-Alanine Aminopeptidase Activated Fluorescent Probe for the Detection of , , and .

Varadi L, Najib E, Hibbs D, Perry J, Groundwater P Molecules. 2019; 24(19).

PMID: 31575027 PMC: 6804094. DOI: 10.3390/molecules24193550.